Kolumne, ORE

Original-Research: ASMALLWORLD AG - from NuWays AG Classification of NuWays AG to ASMALLWORLD AG Company Name: ASMALLWORLD AG ISIN: CH0404880129 Reason for the research: Update Recommendation: BUY from: 15.03.2024 Target price: 4.30 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch FY'23 in line, growth investments to burden profitability; chg.

15.03.2024 - 09:02:33

Original-Research: ASMALLWORLD AG (von NuWays AG): BUY


Original-Research: ASMALLWORLD AG - from NuWays AG

Classification of NuWays AG to ASMALLWORLD AG

Company Name: ASMALLWORLD AG
ISIN: CH0404880129

Reason for the research: Update
Recommendation: BUY
from: 15.03.2024
Target price: 4.30
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Henry Wendisch

FY'23 in line, growth investments to burden profitability; chg.
 
Topic: Yesterday, ASW released FY'23 results, in line on top line and
slightly below estimate and guidance on EBITDA level. Moreover, the
announcement of an 'investment year' should burden FY'24e profitability
temporarily in return for member growth. In detail:
 
Sales came in at CHF 21.2m, +15% yoy (eNuW: CHF 21.1m; guidance: CHF
20-22m) driven by strong growth in both segments: Subscriptions grew by 13%
yoy to CHF 14.8m while Services grew by 20% yoy to CHF 6.5m, thanks member
growth by 6.4% to 70.2k coupled with ARPU growth of 6% yoy.
 
EBITDA came in slightly lower-than-expected at CHF 2.1m (down 16% yoy;
eNuW: CHF 2.3m; guidance: CHF 2.2 - 2.4m) because the product mix shifted
towards the Emirates Skywards program and away from the Lufthansa Miles and
More program, leading to higher costs for member privileges of CHF 13.5m
(+26% yoy).
 
Net income however rose by 6% yoy to CHF 1.53m due to the first time
collection of GHA's dividend of CHF 0.3m, lifting the financial result
accordingly from CHF -0.2m in FY'22 to CHF 0.1m, while EPS is diluted by
the increased no. of shares following the recent capital increase.
 
Growth investments to burden profitability in the near-term: With last
year's acquisition of JetBeds.com, ASW now offers the value luxury travel
service value chain for its customers. Hence, the next logical step is to
increase the customer base of the social network (see p. 2), which should
be achieved by 1) expanding marketing efforts and 2) lowering the entry
threshold with a 'freemium' version, which is currently under evaluation.
Both has a short-term negative effect on profitability, but should ensure
the basis for future growth. Thereafter, the strong operating leverage of
ASW's business should let profitability rise again in FY'25e (eNuW: 11% vs.
4.5% in FY'24e). Moreover, new hires of tech-personnel should also burden
profitability.
 
New guidance reflects growth investments: ASW guides for CHF 23-25m in
sales (eNuW: CHF 24.4m) and an increased member base of 73 - 74k (eNuW:
73.7k), but a decline in EBITDA to CHF 1 - 1.2m (eNuW: CHF 1.1m; old: CHF
3.2m) due the investments mentioned above.
 
At current levels, ASW stock seems to price in the weak profitability for
FY'24e, but the market seems to underestimate the operating leverage the
business provides after this transition year. Hence, we reiterate our BUY
recommendation, but reduce our PT to CHF 4.30 (old: CHF 4.90), as we
decrease our bottom-line estimates and roll over our DCF model.

You can download the research here:
http://www.more-ir.de/d/29167.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden: www.nuways-ag.com/research.
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...